4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cardiol Therapeutics Inc. (CRDL) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Oakville, Canada with about 18 employees. Its market capitalization is roughly $128 million. In the fiscal year ended 2025-12-31, CRDL reported $0M in revenue and ($34M) in net income.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($34M) | ($40M) | ($30M) | ($41M) | — |
| Net Income | ($34M) | ($37M) | ($28M) | ($31M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($10M) | ($8M) | ($10M) | ($8M) | ($8M) | — |
| Net Income | ($11M) | ($7M) | ($10M) | ($8M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $24M | $32M | $37M | $62M | — |
| Total Liabilities | $6M | $7M | $8M | $10M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CRDL viewer.
About TickerBase · Data methodology & sources